How Novo Nordisk partners with academia, biotech companies and beyond
We invite you to an exciting networking event in collaboration with our partner Novo Nordisk, on 27 May 2025. Novo Nordisk’s external innovation teams will be introducing their approach to building partnerships across a diverse spectrum of collaborators, including scientists, academic institutions, startups, biotech innovators, and established pharmaceutical companies.
We will hear about Novo Nordisk R&D’s scientific strategy and therapy approach, as well as partnering opportunities, ranging all the way from collaborations and licensing to equity investments and acquisitions.
Don’t miss this opportunity to expand your professional network and gain knowledge that could inspire your next big idea!
Participation is free. However, registration is required before 20 May 2025.
Program
17:30
Door opening
18:00
Welcome by BaseLaunch
- Virginia Ballotta, Manager New Ventures, BaseLaunch
18:10
Scientific and therapy area strategy of Novo Nordisk R&D
- William Haynes, PhD, Scientific Corporate VP, Novo Nordisk
18:25
Partnering, business development and licensing strategy
- Miriam Frieden, PhD, Corporate VP, Early Innovation, Outreach & Alliances, Novo Nordisk
18:40
Outreach and partnership programs
- Daniel Timmerman, PhD, VP of Innovation Outreach, Global Drug Discovery, Novo Nordisk
18:55
Equity investment program
- Neil Anderson, PhD, Sr. Director, Early Innovation, Outreach & Alliances, Novo Nordisk
19:10
Q&A session
19:30
Networking Apéro